Table 1.

Proinflammatory cytokines

	WT Veh, n = 4	WT Cis, n = 5	IL-33 Def Veh, n = 5	IL-33 Def Cis, n = 5
IL-1, pg/g	74 ± 24	521 ± 141*	46 ± 8	95 ± 30
IL-2, pg/g	72 ± 15	102 ± 19	58 ± 15	113 ± 36
IL-4, pg/g	48 ± 10	34 ± 6	38 ± 8	34 ± 18
IL-5, pg/g	0.01 ± 0.002	0.06 ± 0.04	0.01 ± 0.003	0.02 ± 0.003
IL-6, pg/g	728 ± 210	1,991 ± 318*	562 ± 134	2,113 ± 295**
IL-10, pg/g	87 ± 27	255 ± 21*	73 ± 13	410 ± 67**
IL-12, pg/g	918 ± 277	2,102 ± 254*	899 ± 269	2,686 ± 390**
CXCL1, pg/g	117 ± 47	3,797 ± 368*	184 ± 29	5,954 ± 1,042**
TNF-α, pg/g	55 ± 16	331 ± 62*	54 ± 11	266 ± 21**
IFN-γ, pg/g	4.2 ± 1.5	5.4 ± 0.09	3.1 ± 0.04	4 ± 1.3

WT, wild-type; Veh, vehicle; Cis, cisplatin-induced acute kidney injury; Def, deficient.

^*P < 0.05 vs. WT Veh;

^**P < 0.05 vs. IL-33 Def Veh.